General Information
Revision date
2021-03-09
Product name
Simvastatin
1.2.1 Relevant identified uses
Biochemical research/analysis 1.4
Icons in SDS
Company Information
company name
Merck Sdn. Bhd
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
EU Classification
CLASS regulations 2013 Reproductive toxicity (Category 2), H361d For the full text of the H-Statements mentioned in this Section, see Section 16.
2.2 Label elements
Labelling according to CLASS regulations 2013
Signal word
Warning Warning
Hazard statements
H361d Suspected of damaging the unborn child. none
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant. Reduced Labeling (<= 125 ml)
Precautionary statements
none Refer to the Safety Data Sheet before use.
2.3 Other hazards
Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials. SECTION 3: Composition and information of the ingredients of the hazardous chemical
